Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Matriptase is highly upregulated in chronic lymphocytic leukemia and promotes cancer cell invasion.

Gao L, Liu M, Dong N, Jiang Y, Lin CY, Huang M, Wu D, Wu Q.

Leukemia. 2013 Apr;27(5):1191-4. doi: 10.1038/leu.2012.289. Epub 2012 Oct 9. No abstract available.

PMID:
23044656
2.

Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.

Larsen BR, Steffensen SD, Nielsen NV, Friis S, Godiksen S, Bornholdt J, Soendergaard C, Nonboe AW, Andersen MN, Poulsen SS, Szabo R, Bugge TH, Lin CY, Skovbjerg H, Jensen JK, Vogel LK.

Exp Cell Res. 2013 Apr 1;319(6):918-29. doi: 10.1016/j.yexcr.2013.01.008. Epub 2013 Jan 16.

PMID:
23333561
3.

Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.

List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, Murdock T, Burke B, Nielsen BS, Gutkind JS, Bugge TH.

Genes Dev. 2005 Aug 15;19(16):1934-50.

4.

Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.

Oberst MD, Johnson MD, Dickson RB, Lin CY, Singh B, Stewart M, Williams A, al-Nafussi A, Smyth JF, Gabra H, Sellar GC.

Clin Cancer Res. 2002 Apr;8(4):1101-7.

5.

The hepatocyte growth factor regulatory factors in human breast cancer.

Parr C, Watkins G, Mansel RE, Jiang WG.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):202-11.

6.

Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer.

Nakamura K, Abarzua F, Kodama J, Hongo A, Nasu Y, Kumon H, Hiramatsu Y.

Int J Oncol. 2009 Feb;34(2):345-53.

PMID:
19148468
7.

Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia.

Sulda ML, Abbott CA, Macardle PJ, Hall RK, Kuss BJ.

Cancer Biol Ther. 2010 Jul 15;10(2):180-9. Epub 2010 Jul 26.

PMID:
20534982
9.

Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.

Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin CY.

Am J Pathol. 2001 Apr;158(4):1301-11.

10.

Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

Cheng H, Fukushima T, Takahashi N, Tanaka H, Kataoka H.

Cancer Res. 2009 Mar 1;69(5):1828-35. doi: 10.1158/0008-5472.CAN-08-3728. Epub 2009 Feb 17.

11.

Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1.

Kirchhofer D, Peek M, Li W, Stamos J, Eigenbrot C, Kadkhodayan S, Elliott JM, Corpuz RT, Lazarus RA, Moran P.

J Biol Chem. 2003 Sep 19;278(38):36341-9. Epub 2003 Jun 18.

12.

Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.

Baba T, Kawaguchi M, Fukushima T, Sato Y, Orikawa H, Yorita K, Tanaka H, Lin CY, Sakoda S, Kataoka H.

J Pathol. 2012 Oct;228(2):181-92. doi: 10.1002/path.3993. Epub 2012 Apr 18.

PMID:
22262311
13.

Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia.

Molica S, Vacca A, Crivellato E, Cuneo A, Ribatti D.

Eur J Haematol. 2003 Aug;71(2):137-9. No abstract available.

PMID:
12890156
15.

Deregulated activation of matriptase in breast cancer cells.

Benaud CM, Oberst M, Dickson RB, Lin CY.

Clin Exp Metastasis. 2002;19(7):639-49.

PMID:
12498394
16.

The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.

Vogel LK, Saebø M, Skjelbred CF, Abell K, Pedersen ED, Vogel U, Kure EH.

BMC Cancer. 2006 Jul 4;6:176.

17.
18.

The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor.

Oberst MD, Williams CA, Dickson RB, Johnson MD, Lin CY.

J Biol Chem. 2003 Jul 18;278(29):26773-9. Epub 2003 May 8.

19.

Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients.

Parr C, Sanders AJ, Davies G, Martin T, Lane J, Mason MD, Mansel RE, Jiang WG.

Clin Cancer Res. 2007 Jun 15;13(12):3568-76.

20.

The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).

Peng B, Zhang M, Sun R, Lin YC, Chong SY, Lai H, Stein D, Raveche ES.

Leuk Res. 1998 Jun;22(6):509-16.

PMID:
9678717
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk